Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. Working Party on Leukaemia of the Swiss Group for Epidemiologic and Clinical Cancer Research (SAKK).
Wernli M, Tichelli A, von Fliedner V, Brun del Re G, Chapuis B, Fey MF, Fopp M, Gmür J, Grob JP, Jacky E, et al. Wernli M, et al. Among authors: fopp m. Br J Haematol. 1994 May;87(1):39-43. doi: 10.1111/j.1365-2141.1994.tb04867.x. Br J Haematol. 1994. PMID: 7947254 Clinical Trial.
Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A, van Hille B, Bacchi M, Fopp M, Joncourt F, Reuter J, Cerny T, Fey MF, Herrmann R. Lohri A, et al. Among authors: fopp m. Eur J Haematol. 1997 Oct;59(4):206-15. Eur J Haematol. 1997. PMID: 9338618 Clinical Trial.
MTS1 expression and prognosis in acute myeloid leukemia.
Rochlitz CF, Lohri A, Sasse-Roth G, van Hille B, Reuter J, Tichelli A, Bacchi M, Fopp M, Fey MF, Herrmann R. Rochlitz CF, et al. Among authors: fopp m. Ann Hematol. 1997 Oct;75(4):141-4. doi: 10.1007/s002770050331. Ann Hematol. 1997. PMID: 9402846
Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).
Rochlitz C, Lohri A, Bacchi M, Schmidt M, Nagel S, Fopp M, Fey MF, Herrmann R, Neubauer A. Rochlitz C, et al. Among authors: fopp m. Leukemia. 1999 Sep;13(9):1352-8. doi: 10.1038/sj.leu.2401484. Leukemia. 1999. PMID: 10482985 Clinical Trial.
34 results